Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Depreciation and Depletion: 2019-2024

Historic Depreciation and Depletion for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Dec 2024 value amounting to $20.9 million.

  • Maravai Lifesciences Holdings' Depreciation and Depletion rose 18.46% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.1 million, marking a year-over-year increase of 19.77%. This contributed to the annual value of $20.9 million for FY2024, which is 62.02% up from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Depreciation and Depletion of $20.9 million as of FY2024, which was up 62.02% from $12.9 million recorded in FY2023.
  • Maravai Lifesciences Holdings' Depreciation and Depletion's 5-year high stood at $20.9 million during FY2024, with a 5-year trough of $5.6 million in FY2020.
  • Moreover, its 3-year median value for Depreciation and Depletion was $12.9 million (2023), whereas its average is $13.8 million.
  • Data for Maravai Lifesciences Holdings' Depreciation and Depletion shows a peak YoY surged of 69.74% (in 2023) over the last 5 years.
  • Maravai Lifesciences Holdings' Depreciation and Depletion (Yearly) stood at $5.6 million in 2020, then increased by 14.52% to $6.4 million in 2021, then rose by 18.51% to $7.6 million in 2022, then soared by 69.74% to $12.9 million in 2023, then soared by 62.02% to $20.9 million in 2024.